Direct and Indirect Cost Burden of Ulcerative Colitis: A Matched Analysis of Healthcare Costs, Absenteeism, and Short Term Disability Costs in US Patients With and Without Ulcerative Colitis

被引：0

作者：

Meek, Patrick D.

Racz, Michael J.

Kehoe, James E.

Cosler, Leon E.

Carter, Judith A.

Yen, Linnette

机构：

来源：

GASTROENTEROLOGY | 2013年 / 144卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S765 / S765

页数：1

共 50 条

[41] EPIDEMIOLOGY, HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS IN TAIWAN: A NATIONAL HEALTH INSURANCE RESEARCH DATABASE (NHIRD) STUDY
Tang, C. H.
Wei, A.
Newson, R. S.
Ng, K. J.
Shen, D.
Wang, B.
VALUE IN HEALTH, 2024, 27 (06) : S364 - S365
[42] SHORT-TERM DIRECT AND INDIRECT COST BURDEN OF CARDIOVASCULAR EVENTS IN PATIENTS WITH A HISTORY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN THE US
Johnson, B. H.
Bonafede, M. M.
Rane, P. B.
Patel, J.
Harrison, D. J.
VALUE IN HEALTH, 2017, 20 (09) : A612 - A612
[43] Correction to: Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis
Celine Miyazaki
Takuya Sakashita
Wonjoo Jung
Shingo Kato
Advances in Therapy, 2021, 38 : 2248 - 2248
[44] COST PER RESPONDER ANALYSIS OF BIOLOGIC TREATMENTS FOR ULCERATIVE COLITIS IN BIOLOGIC NAIVE PATIENTS FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
Souza, P. V. S.
Baida, R.
Gomes, T. N. F.
VALUE IN HEALTH, 2020, 23 : S532 - S532
[45] COST-EFFECTIVENESS ANALYSIS OF MIRIKIZUMAB VERSUS USTEKINUMAB IN ADVANCED THERAPY EXPERIENCED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE US
Wang, Xuan
Bakker, Lytske
Upadhyay, Navneet
Hartz, Susanne
Treur, Maarten
Svedbom, Axel
INFLAMMATORY BOWEL DISEASES, 2024, 30 : S44 - S45
[46] COST-EFFECTIVENESS ANALYSIS OF MIRIKIZUMAB VERSUS USTEKINUMAB IN ADVANCED THERAPY EXPERIENCED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE US
Wang, Xuan
Bakker, Lytske
Upadhyay, Navneet
Hartz, Susanne
Treur, Maarten
Svedbom, Axel
GASTROENTEROLOGY, 2024, 166 (03) : S61 - S62
[47] Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis
Yang, Z.
Wu, Q.
Wu, K.
Fan, D.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (04) : 486 - 492
[48] Symptom burden and lack of remission among adult patients with ulcerative colitis (UC): retrospective analysis of cross-sectional survey data from the US and Germany
Gorsh, B.
Bracher, M.
Symons, J. M.
Nafees, B.
Chauhan, D.
Hoskin, B.
Lucas, J.
Kershaw, J.
Middleton, C.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S515 - S516
[49] Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland
Malinowski, Krzysztof Piotr
Kawalec, Pawel Piotr
Mocko, Pawel
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (02) : 295 - 303
[50] Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Control Cohort Analysis
Aki Shiozawa
Sari Hopson
Rupali Fuldeore
Matthias Stoelzel
Daniel Ng
John Hairston
Advances in Therapy, 2020, 37 : 4599 - 4613

← 1 2 3 4 5 →